VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 13.93
-0.07 (-0.50%)
Oct 30, 2026, 3:59 PM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 1.52 billion as of October 30, 2026. It is the 20,742nd most valuable company in the world and the 947th biggest in Hong Kong. Its market cap has decreased by 63.78% in one year.
Market Cap
1.52B
Enterprise Value
1.14B
Revenue
39.32M
Global Rank
Country Rank
#947 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 1.52B, a decrease of -78.84%. That is a compound annual growth rate of -61.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.52B | -55.80% |
| Dec 31, 2025 | 3.44B | -52.13% |
| Mar 21, 2025 | 7.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CF PharmTech | 2.27B |
| Hua Medicine (Shanghai) | 2.17B |
| CPBIO Holding Company | 1.98B |
| Jacobson Pharma Corporation | 1.87B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.48B |
| Golden Throat Holdings Group Company | 1.44B |
| Dawnrays Pharmaceutical (Holdings) | 1.39B |
| JBM (Healthcare) | 1.36B |